Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of BMMNCs in Chronic Renal Failure
NCT01876017Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in chronic kidney disease (CKD), sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01876017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01876017.